// App-Quantinova.ai

2693493 : Neurodevelopmental Outcomes in Infants Treated for Retinopathy of Prematurity: bevacizumab versus laser

Researchers

Presenter

  • Maram Isaac

Principal Investigators

  • Kamini Raghuram

  • Alaa Alali

  • Kamiar Mireskandari

  • Prakesh Shah

  • Nasrin Najm Tehrani

Medical Centers

  • University of Toronto, Toronto, ON, Canada

  • Ophthalmology & Vision Sciences, University of Toronto Toronto ON Canada

  • Ophthalmology & Vision Sciences, The Hospital for Sick Children, Toronto, Ontario, Canada

  • Departments of Paediatrics and Institute of HPME , University of Toronto , Toronto, Ontario, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Bevacizumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved